Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check10 days agoChange DetectedThe website footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedNew revision v3.7.0 appears in the record history, replacing the older v3.6.6. This reflects an update to the page version rather than changes to the study data.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a new version of the page rather than any substantive content changes.SummaryDifference0.1%

- Check73 days agoChange DetectedA new history entry for Revision v3.6.5 (dated 2026-08-04/05) adds the Study Status and Contacts/Locations sections to the record. The previous Revision v3.6.4 (dated 2026-05-11) is removed.SummaryDifference0.4%

- Check88 days agoChange DetectedNew revision entry v3.6.4 appears in the Study Record History, replacing the previous v3.6.3 and indicating an update to the record's documentation. This update is a version bump in the history rather than a substantive change to the study content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.